Beeline Medicines launches with $300 million from Bain Capital and five drug programs from Bristol Myers Squibb, including a ...
Preview this article 1 min CTI's CEO succession plan was years in the making, and the transition comes as the Covington-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results